Objectives: Prior to 2012, detection of major CHA had been based mainly on combined first trimester or integrated screening and ultrasound examinations. High-risk cases had been offered invasive diagnostics and karyotyping. The implementation of non-invasive prenatal screening (NIPS) might lead to a decrease of invasive tests causing lower accidental detection of other autosomal aberrations than trisomies 21, 18, 13 in the population. We tested the hypothesis, that the ratio of prenatally diagnosed CHA has been changed since the gradual implementation of NIPS after 2012. Methods: We used data from the National Registry of Congenital Anomalies including the individually collected data on prenatally diagnosed cases. We have analysed the prenatally diagnosed cases of all CHA (ICD-10 codes: Q90-Q99) during the 2012-2015 time period. The numbers were evaluated for the group of main autosomal trisomies and ''other'' CHA separately. The time trends were statistically evaluated using GraphPad InStat statistical software. Results: The number of invasive procedures, amniocenteses and chorion biopsies decreased from 11407 in the year 2012 to 7680 in 2015. A total of 575 cases of CHA were identified in 2012, of which 329 cases (57.5%) were trisomies 21, 18 and 13. In 2015, 577 cases of all CHA were identified, with major trisomies contributing 374 cases (64.8%). Thus there was no significant change in the proportion of group of major autosomal trisomies, compared to the ''other'' CHA (p>0.05). During the study period the total number of prenatally diagnosed CHA was 2369; major trisomies contributed 1462 cases (76.3%). Conclusions: We were not able to confirm, that the implementation of NIPS with consequent decrease of invasive procedures would lead to less recognition of other unbalanced CHA, that could also have severe phenotypical features for the fetus and/or infant. The overall ratio of prenatally diagnosed trisomies 21,13,18 and ''other'' autosomal aberrations remained unchanged.
Supported 
Methods:
We performed a validation of our set-up and evaluated technical, maternal and fetal characteristics of 'no-call' cases. NIPT analyses were performed on circulating cell-free DNA and Massive Parallel whole-genome Sequencing on a HiSeq1500 (Illumina). Bioinformatics were performed in samples with > 8 mio. reads using a pipeline for fetal fraction (SeqFF) and aneuploidy by WISECONDOR. Data analysis for aneuploidy and fetal sex were accepted in samples with a fetal fraction (FF) above 0.02 and 0.025, respectively. Results: Among 205 selected cases (incl. 73 aneuploidy cases), 13 lead to 'no-call' results (6%). In four euploid cases the reason was technical (BAD cluster) and in nine cases FF was below cut-off (0.02). The gestational age among 'no-calls' ranged from 12 weeks + 3 days to 15 weeks + 2 days. The number of reads ranged from 8 to 34 mio. In the group of 'no-calls' caused by low FF two cases had a maternal BMI>40, four cases had a BMI between 30 and 40, and three cases had a BMI<30. Furthermore, in the group of cases with low FF we found a high number of aneuploidy cases (T21=2, T18=4, T13=1, euploid=2). The Z-scores (ChrW) among the seven aneuploidy cases with a low FF ranged from 0.08 to 6 (cut-off=3). Two cases of T18 and one case of T13 had a Z-score >3 despite a low FF. If the fetal fraction had not been determined four aneuploidy cases might have been false negative. Conclusions: High maternal BMI and fetal aneuploidy highly influence the risk of a 'no-call' result. Therefore, labs performing NIPT in a population with a high number of obese women might have a higher 'no-call' rate. We found a high number of aneuploidy cases among 'no-calls'. Only T18 and T13 are described in the literature to have decreased FF. If we had not included determination of FF in our set-up, four cases might have been false negative.
Objectives: Cervical cerclage is performed in patients with cervical insufficiency to reduce risks of abortion/extreme prematurity. Severe complications can occur if performed in patients with intra-amniotic infection. High levels of intraamniotic interleukin-6 (IL-6) are associated with histological chorioamnionitis. In expert hands amniocentesis is considered a safe procedure which we use routinely in management of PPROM. The aim of our study is to validate our strategy -diagnostic amniocentesis prior to cerclage. Methods: Prospective cohort study in Centre of Fetal Medicine in 2014-16. We included 29 patients with cervical insufficiency eligible for emergency cerclage. In all cases we performed transabdominal amniocentesis. Amniotic fluid was tested for IL-6 (Roche Diagnostics) and bacterial DNA (PCR Mycoplasma, Ureaplasma). In patients with IL-6 <2000 ng/l McDonald transvaginal cerclage with Mersilene tape (Ethicon) was performed. Between 2000-4999 ng/l therapeutic dose of IV antibiotics was administered (Clarithromycin or Clindamycin) and amniocentesis was repeated in one week. If IL-6 lower, we performed cerclage. Patients with IL-6 >5000 ng/l were ruled out and managed conservatively. Results: We performed 29 amniocenteses. 21 patients were tested negative and proceeded with cerclage. 4 intermediate received antibiotics, had second amniocentesis (all with lower IL-6) and a cerclage afterwards. 4 patients were ruled out and managed expectantly. We performed cerclage in 25 cases. Mean gestational age at surgery was 22.1 (min 16.2, max 26.0). Mean IL-6 was 1046 ng/l (min 215, max 4254). In 1 case there was an abortion after cerclage. In all other 24 cases (96%) live fetuses were born. Mean gestational age at delivery 33.1 (min 24.5, max 41.1), mean birth weight 2072g (min 542, max 3770). Out of the 4 ruled out patients: 3 had a septic abortion within 1 week, 1 patient had an emergency Caesarean at 26 weeks for sepsis and bleeding. Conclusions: Invasive diagnostic to rule out intra-amniotic infection seems beneficial before emergency cerclage. Objectives: Standard transabdominal CVS (TA-CVS) may be difficult due to axial-retroverted uterus, a posterior low-lying placenta with interposed bowel or uterine myomas, and alternative approaches are required. We analysed our series of difficult CVS procedures to evaluate the effectiveness of the percutaneous transvesical approach (TV-CVS). Methods: Retrospective analysis of patients with difficult CVS, in which a secondary evaluation was required. Abdominal pressure or vaginal manipulation of the cervix were applied to enable the TA-CVS. If this was not possible, TV-CVS was indicated and a full bladder was required. The TV-CVS technique was performed free-hand transabdominally with ultrasound-guided insertion of a 15-cm/17-gauge Chiba needle, under local anesthesia. The needle entered the bladder and then the placenta parallel to its longest axis to sample by continuous aspiration with a 20-mL syringe. Results: A total of 1182 CVS procedures were performed in our centre from 2009 to 2015. In 95 (8.0%) cases the procedure was considered difficult, however a secondary evaluation achieved exposure or adequate sampling window with successful TA-CVS in 45 (47.3%) cases whereas in 50 (52.6%) cases a TV-CVS was performed. In our series of TV-CVS procedures, an adequate sample (>10 mg) was retrieved in all cases with single placental pass. There were: two (4.0%) cases of light postprocedure bleeding, two (4.0%) cases with vasovagal response, one (2.0%) with small subcutaneous hematoma and in another (2.0%) there was a failure of the long-term villi culture, no cases of hematuria or lower urinary tract disorders.
In the total group of 1182 CVS procedures, there were five miscarriages (1/236 of those with no TOP) at 12-24 weeks with none among the 50 patients undergoing TV-CVS. Conclusions: In our experience TV-CVS appears effective and it may be essential in specific high-risk cases in which the TA-CVS sampling window is obstructed. Lower urinary tract infection may impair cell culture growth, however this may be less relevant using microraray techniques. Methods: A single-centre cohort study of twin pregnancies complicated by TTTS and treated by Laser. Data from the pre-Laser ultrasound scans, antenatal records, and post-treatment follow-up scans were collected. Pregnancies complicated by major structural anomalies, TAPS, loss-to-follow-up, and repeat Laser procedures were excluded from the analysis. The primary outcome measure was IUD of one or both twins. Results: 280 pregnancies were included in the analysis. The median gestational age at treatment was 19.7 weeks (IQR: 17.7-22.2 weeks). The survival rates of at least one and of both twins were 74.4% and 52.8%, respectively. Donor survival was significantly lower than recipient twin (54.3% vs 67.2%, P=0.001). The incidence of IUD of either twin was 16.4%. In the univariate model an estimated fetal weight discordance of 30% or more [OR 1.71 (95%CI: 0.99,3.01; P=0.05)], ductus venous PI of the donor [OR 3.24 (95%CI: 1.09,10.93, P=0.04)] and absent/reversed end-diastolic flow (AREDF) in the umbilical artery of the donor [OR: 2.04 (95%CI: 1.11,3.84, P=0.02)] were significantly associated with the risk of IUD (P<0.05). However, in the multivariate logistic regression analysis, only AREDF in the umbilical artery of the donor was significantly associated with the risk of IUD [OR 2.10 (95%CI: 1.14,3.97, P=0.01)]. Placental location (P=0.29), cord insertion site (P=0.48), Quintero stage of the recipient (P=0.11) or of the donor (P=0.31), the recipient umbilical artery (P=0.67) and ductus venosus (P=0.99) Doppler parameters were not significantly associated with the risk of IUD. Conclusions: Both twins survived in approximately half of cases. AREDF in the umbilical artery of the donor is associated with a two-fold increased risk of IUD.
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